直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Media Mention

Exporting a Single Commodity Can't Trigger Patent Liability, Supreme Court Rules

February 22, 2017

Forbes

The Supreme Court recently issued its decision in Life Technologies v. Promega, a case that involved exporting a commonly used laboratory chemical that had been combined into a patented product overseas. The Court reversed the Federal Circuit's decision, ruling that a single commodity can't trigger patent liability because that doesn’t comply with the requirement that an infringer export "all or a substantial portion" of the "components" needed to create a patented product. Forbes contacted Finnegan attorney Doris Johnson Hines for her thoughts on the decision.

Hines said that the decision somewhat clarifies the law, but still leaves substantial unanswered questions. While the court judged "components" by quantity and not their qualities, Hines said, "...it's unclear to me what a component of a claimed invention is." She added, "Lawyers can draft a patent to claim complex 'components' or break them down into smaller parts, for example, claiming the touchpad, handset, and cords of a telephone as part of a telephone videoconferencing system instead of just a telephone and a video monitor. [But] what if a company exported handsets and cords for use in an infringing videoconferencing system overseas? Would they meet the 'substantial portion' test where a single 'telephone' would not?"

Tags

Life Technologies Corp. v. Promega Corp., Supreme Court of the United States (SCOTUS)

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Related Industries

Chemicals, Industrials, and Materials

Chemical

Energy

Life Sciences

Biotechnology

Related News

Commentary

Patent Strategy Could Shape Financing, Valuation and Risk in Offshore Energy Projects

June 30, 2026

Award/Ranking

Finnegan’s European Practices and Attorneys Highlighted in 2026 Managing IP Rankings

June 25, 2026

Commentary

Zync Fights Block of ITC Trade Secret Case Against BMW

June 24, 2026

Press Release

BMW Obtains Preliminary Injunction Against Zync; Federal Court Orders Zync to Halt ITC Trade Secret

June 23, 2026

Commentary

BMW Secures Injunction Forcing Zync to Seek Stay of ITC Trade Secret Case

June 23, 2026

Award/Ranking

Six Finnegan Partners Recognized in the 2026 Lawdragon 500 Leading Global IP Lawyers

June 22, 2026

Award/Ranking

Finnegan Recognized in 2026 BTI Client Service A-Team Rankings

June 22, 2026

Commentary

U.S. Judge Rules Forum-Selection Clause Bars Zync from Pursuing ITC Trade Secret Case

June 15, 2026

Commentary

Finnegan Taps Partner from Kirkland to Boost IP Team

June 12, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP